Alan S Forman

CIK 1309439 · last filed 2026-05-01

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$58.9K

Companies

2

Total Filings

19

Lifetime Open-Market Net

$141.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
JBGS Director 4,000 $14.72 $58.9K $121.6K 11 2026-05-01
STEMLINE THERAPEUTICS INC (STML) Delisted Director 0 $20.0K 8 2020-06-10

Recent Filings · Page 2 of 2

19 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-12-04 STEMLINE THERAPEUTICS INC (STML) Delisted Buy (P) +1,000 $10.3K EDGAR
2019-06-28 STEMLINE THERAPEUTICS INC (STML) Delisted Grant (A) +15,000 $0 EDGAR
2019-05-06 JBGS Grant (A) $0 EDGAR
2018-06-22 STEMLINE THERAPEUTICS INC (STML) Delisted Grant (A) +13,158 $0 EDGAR
2018-05-07 JBGS Grant (A) $0 EDGAR
2017-07-20 JBGS Grant (A) $0 EDGAR
2017-06-20 STEMLINE THERAPEUTICS INC (STML) Delisted Grant (A) +10,000 $0 EDGAR
2016-05-26 STEMLINE THERAPEUTICS INC (STML) Delisted Grant (A) $0 EDGAR
2015-06-25 STEMLINE THERAPEUTICS INC (STML) Delisted Grant (A) +5,000 $0 EDGAR
Showing 1119 of 19
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.